| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $9.8M | +5.2% |
| SG&A Expense | $6.2M | +10.7% |
| Operating Income | -$16.0M | -7.3% |
| Income Tax | $0 | — |
| Net Income | -$15.9M | -6.7% |
| EPS (Basic) | -$35.75 | +8.0% |
| EPS (Diluted) | -$35.75 | +8.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.2M | +11.4% |
| Current Assets | $8.1M | -6.4% |
| Total Assets | $8.6M | -0.9% |
| Current Liabilities | $4.1M | +62.5% |
| Total Liabilities | $4.1M | +62.5% |
| Stockholders' Equity | $4.5M | -26.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$13.8M | +19.3% |
| Capital Expenditures | $18K | +334.0% |
| Investing Cash Flow | -$18K | -334.0% |
| Financing Cash Flow | $14.6M | -36.7% |
| Free Cash Flow | -$13.8M | +19.2% |